611
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b

, , &
Pages 2530-2537 | Received 21 Nov 2019, Accepted 06 Mar 2020, Published online: 05 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tao Liu, Fei Jiang, Li-Yuan Yu & You-Yang Wu. (2022) Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation. Bioengineered 13:3, pages 6359-6370.
Read now
Fang Liu, Yanfen Shi, Zuolong Liu, Ziyi Li & Wei Xu. (2021) The emerging role of miR-10 family in gastric cancer. Cell Cycle 20:15, pages 1468-1476.
Read now

Articles from other publishers (11)

Ao-Yu Li, Hui-Ni Xiao, Zi-Yue Zhao, Cheng Xiang, Zhuo-yuan Chen, Ping-xiao Wang, Yu Xia, Bin Yu, Hui Li & Tao Xiao. (2023) Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation. Journal of Cancer Research and Clinical Oncology 149:11, pages 9105-9128.
Crossref
Aida Raigon Ponferrada, Salvador Romero Molina, Juan Carlos Molina Ruiz, Gomez Maldonado Josefa & Jose Luis Guerrero Orriach. (2023) Anesthesia and Cancer: Something More than Avoiding Stress Response. Current Gene Therapy 23:4, pages 261-275.
Crossref
Kanwal Asif, Muhammad Adeel, Md. Mahbubur Rahman, Isabella Caligiuri, Tiziana Perin, Maja Cemazar, Vincenzo Canzonieri & Flavio Rizzolio. (2023) Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy. Journal of Materials Chemistry B 11:14, pages 3124-3135.
Crossref
Marina Leite, Raquel Seruca & Jorge M. Gonçalves. 2023. Hereditary Gastric and Breast Cancer Syndrome. Hereditary Gastric and Breast Cancer Syndrome 281 320 .
Lucillia Bezu, Oliver Kepp & Guido Kroemer. (2022) Impact of local anesthetics on epigenetics in cancer. Frontiers in Oncology 12.
Crossref
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Nadine De Godoy Torso, Marília Berlofa Visacri, Patricia Moriel & Luis A. Salazar. (2022) Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Frontiers in Pharmacology 13.
Crossref
Peyman Tabnak, Soroush Masrouri, Kiarash Roustai Geraylow, Mahtab Zarei & Zanyar Haji Esmailpoor. (2021) Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives. Biomedicine & Pharmacotherapy 144, pages 112309.
Crossref
Thomas P. Wall & Donal J. Buggy. (2021) Perioperative Intravenous Lidocaine and Metastatic Cancer Recurrence - A Narrative Review. Frontiers in Oncology 11.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Kiavash Hushmandi, Vahid Rahmanian, Maliheh Entezari, Yarabahally R. Girish, Kothanahally S. Sharath Kumar, Amir Reza Aref, Pooyan Makvandi, Milad Ashrafizadeh, Ali Zarrabi & Haroon Khan. (2021) Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy. Life Sciences 277, pages 119430.
Crossref
Caihui Zhang, Cuiyu Xie & Yao Lu. (2021) Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence. Frontiers in Oncology 11.
Crossref
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, Hossein Saleki, Seyed Mohammad Reza Torabi, Adnan Ranjbar, SeyedHesam SeyedSaleh, Seyed Omid Sharifzadeh, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi & Kwang-seok Ahn. (2021) Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 26:8, pages 2382.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.